Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3048% above fair value
$28.86−0.03 (-0.10%)
Close on Nov 16, 2026Market cap $164.49BP/E 38.0Yield 5.96%
Pfizer pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Pfizer's pe ratio was 38.6× on Nov 10, 2026, against 15.0× a year earlier. Over the last 5 years it ranged from 7.1× to 75.0×, with a median of 15.8×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 38.6× | +24.2 |
| 2025 | Dec 31, 2025 | 14.5× | −20.9 |
| 2024 | Dec 31, 2024 | 35.4× | +19.6 |
| 2023 | Dec 29, 2023 | 15.7× | +5.9 |
| 2022 | Dec 30, 2022 | 9.9× | −7.5 |
| 2021 | Dec 31, 2021 | 17.3× | −9.4 |
| 2020 | Dec 31, 2020 | 26.7× | +13.0 |
| 2019 | Dec 31, 2019 | 13.7× | +2.7 |
| 2018 | Dec 31, 2018 | 11.0× | −11.3 |
| 2017 | Dec 29, 2017 | 22.4× | −9.8 |
| 2016 | Dec 30, 2016 | 32.2× | +7.9 |
| 2015 | Dec 31, 2015 | 24.3× | +5.0 |
| 2014 | Dec 31, 2014 | 19.2× | +10.7 |
| 2013 | Dec 31, 2013 | 8.5× | −11.0 |
| 2012 | Dec 31, 2012 | 19.4× | +4.5 |
| 2011 | Dec 30, 2011 | 14.9× | −7.8 |
| 2010 | Dec 31, 2010 | 22.7× | +7.7 |
| 2009 | Dec 31, 2009 | 15.0× | – |
See a number that looks wrong?